FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls (Q33829236)

29 July 2017

0 references

FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls (English)

1 reference

29 July 2017

1 reference

1 reference

Bin Xu

1

1 reference

29 July 2017

Na Tong

2

1 reference

29 July 2017

Shu Q Chen

3

1 reference

29 July 2017

Li X Hua

4

1 reference

29 July 2017

Zeng J Wang

5

1 reference

29 July 2017

Zheng D Zhang

6

1 reference

29 July 2017

Ming Chen

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

24 February 2011

1 reference

29 July 2017

1 reference

29 July 2017

11

1 reference

29 July 2017

84

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-11-84

29 July 2017

0 references

cites work

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Fibroblast growth factor 17 is over-expressed in human prostate cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Statistical aspects of the analysis of data from retrospective studies of disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Fibroblast growth factors, their receptors and signaling

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Quantitative synthesis in systematic reviews

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Bias in meta-analysis detected by a simple, graphical test

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Operating characteristics of a rank correlation test for publication bias

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Functions of fibroblast growth factors and their receptors

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Meta-analysis in clinical trials

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population

4 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-84

The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-84

Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-84

MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: A meta-analysis of 3511 cases and 2762 controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-84

FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049742

Functional FGFR4 Gly388Arg Polymorphism Predicts Prognosis in Lung Adenocarcinoma Patients

29 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-84

Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high‐grade soft tissue sarcoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21349172

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-11-84

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference